Mindpeak

Company profile

About Mindpeak

Mindpeak is a digital pathology AI company that transforms tissue samples into high-dimensional data to enable precision medicine and targeted therapies. Founded in 2018 and headquartered in Hamburg, Germany, with a US presence in Cambridge, Massachusetts, the company has developed a proprietary AI frontier model called peakFrontier built on seven years of clinical validation and five million expert annotations. The company serves two primary markets: biopharma partners seeking biomarker discovery, clinical trial support, and companion diagnostics development, and diagnostic laboratories requiring automated, reproducible analysis of tissue images. Mindpeak's technology decodes complex biological patterns invisible to the human eye, analyzing multi-modal images including H&E, IHC, and multiplex immunofluorescence to characterize the tumor microenvironment and predict therapy response. The platform segments tissue into 12 distinct classes, classifies cells into 13 types, and performs sub-cellular segmentation of nucleus, cytoplasm, and membrane. With 11 CE-IVD certified products, ISO 13485 QMS certification, and integration with 18+ image management systems across 40+ labs worldwide, Mindpeak provides an established commercial ecosystem for deploying AI-driven diagnostics at scale. The company's product suite includes peakDiscover for biomarker discovery, peakPredict for patient selection, peakDeploy for global scaling, peakDx for clinical diagnostics, peakDissect for tissue optimization, and peakAcademy for pathologist training across more than 20 countries.

Company description · Mindpeak official website